HSS is the #1 orthopedic hospital in the world and a national leader in rheumatology. This content was created by our physicians and experts. Adapted from a presentation to the SLE Workshop at HSS By ...

Brazil has not yet tested cows for bird flu, despite hundreds of cases in the dairy herd in the U.S., because it is focusing on poultry outbreaks after its first confirmed case on a farm this ...

Nivolumab plus ipilimumab showed a significant overall survival benefit versus lenvatinib or sorafenib and manageable safety in patients with previously untreated unresectable hepatocellular carcinoma ...

The "Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route of Administration, Distribution Channel, ...

In a report, the FDA says a total of 1,584,780 single-dose packages of Esomeprazole Magnesium for Delayed-Release Oral Suspension were recalled nationwide starting on May 13. Esomeprazole, sometimes ...

New Delhi: With the condition of conducting a Phase IV clinical trial study, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted ...

Shares of AstraZeneca have outperformed the Zacks Medical - Biomedical and Genetics industry over the year-to-date period (+9% vs. -5%). The company beat Q1 estimates for earnings but missed on sales.

AstraZeneca PLC (LSE/STO/Nasdaq:LON: AZN), the global biopharmaceutical company, has announced the completion of its acquisition of EsoBiotec, a biotech company specializing in cell therapies, for a ...

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and Shell plc (SHEL), as well as two micro-cap stocks Ocean Power ...

Claim: A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin.

AstraZeneca said the transaction will not affect its financial guidance for 2025. Shares in AstraZeneca were up 0.1% at 10,380.00 pence each in London on Tuesday. By Eva Castanedo, Alliance News ...